Several of the main biologically targeted drugs currently available for asthma target key pathways in the pathogenesis of asthma are: IgE, interleukin (IL)-5, and IL-4/IL-13, all of which modulate Th2-type inflammation, and which therefore may share some common characteristics in their target populations [13]. Here, IL4 is linked to asthma.